Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05270382 · ClinicalTrials.gov registry record · NA
Effect of Mouthwashes on Oral Wound Healing and Microbiome
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT05270382 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 34 participants.
The verdict
NCT05270382, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this clinical research study is to investigate if mouthwashes to be tested can affect oral mucosal wound healing and change the oral microbiome (bacteria colonization) or expression of selected biomarkers.
Interventions
- OTHER cetylpyridinium chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05270382
The ClinicalTrials.gov registry entry for NCT05270382 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cetylpyridinium chloride is the first listed.
NCT05270382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05270382 about?
NCT05270382 is a clinical study titled "Effect of Mouthwashes on Oral Wound Healing and Microbiome". The purpose of this clinical research study is to investigate if mouthwashes to be tested can affect oral mucosal wound healing and change the oral microbiome (bacteria colonization) or expression of selected biomarkers.
What is the current status of trial NCT05270382?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2020-02-01. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT05270382?
The interventions under investigation include: cetylpyridinium chloride (OTHER).
Who is sponsoring clinical trial NCT05270382?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.